
Sign up to save your podcasts
Or


Celgene buys Juno Theraputics. Halliburton delivers results in the 4th quarter and optimism for 2018. Abercrombie & Fitch soars 10% on a better-than-expected holiday season. Jason Moser and Taylor Muckerman analyze those stories and discuss opportunities in the energy industry.
By The Motley Fool4.7
16041,604 ratings
Celgene buys Juno Theraputics. Halliburton delivers results in the 4th quarter and optimism for 2018. Abercrombie & Fitch soars 10% on a better-than-expected holiday season. Jason Moser and Taylor Muckerman analyze those stories and discuss opportunities in the energy industry.

3,221 Listeners

1,499 Listeners

806 Listeners

950 Listeners

523 Listeners

1,177 Listeners

2,170 Listeners

826 Listeners

1,418 Listeners

1,040 Listeners

9,628 Listeners

192 Listeners

810 Listeners

76 Listeners

563 Listeners

984 Listeners

44 Listeners